Amarex Clinical Research
Amarex Clinical Research is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma
Sponsor Aim Immunotech Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Multicenter, Open-Label, Dose Escalation Study of the Safety, Tolerability, and Efficacy of Budiodarone for the Treatment of Subjects with Non-permanent Atrial Fibrillation
Sponsor Xyra LLC
- Start (EU)
- Latest update
- Estimated end
An Adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy with Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
Sponsor Syneurx International (Taiwan) Corp.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Amarex Clinical Research?
The 2026-10-09 snapshot links Amarex Clinical Research to 3 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Data management, Medical writing, Clinical monitoring, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Amarex Clinical Research?
The most frequently recorded therapeutic areas are Gastroenterology, Solid Tumor Oncology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Amarex Clinical Research conducted?
The linked trials record locations in 2 countries, including Poland, Netherlands. These are trial locations, not confirmed office locations or countries where Amarex Clinical Research delivered services.
What can this page tell me about Amarex Clinical Research's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Amarex Clinical Research. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Amarex Clinical Research LLC